AU642961B2 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU642961B2
AU642961B2 AU71029/91A AU7102991A AU642961B2 AU 642961 B2 AU642961 B2 AU 642961B2 AU 71029/91 A AU71029/91 A AU 71029/91A AU 7102991 A AU7102991 A AU 7102991A AU 642961 B2 AU642961 B2 AU 642961B2
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
acceptable salts
relates
physiologically acceptable
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU71029/91A
Other versions
AU7102991A (en
Inventor
Manfred Dr. Baumgarth
Rolf Dr. Bergmann
Rolf Dr. Gericke
Ingeborg Dr. Lues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU7102991A publication Critical patent/AU7102991A/en
Application granted granted Critical
Publication of AU642961B2 publication Critical patent/AU642961B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a pharmaceutical preparation containing bisoprolol and/or one of its physiologically acceptable salts and a potassium channel activator.
AU71029/91A 1990-02-13 1991-02-13 Pharmaceutical composition Ceased AU642961B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4004268A DE4004268A1 (en) 1990-02-13 1990-02-13 PHARMACEUTICAL PREPARATION
DE4004268 1990-02-13

Publications (2)

Publication Number Publication Date
AU7102991A AU7102991A (en) 1991-08-15
AU642961B2 true AU642961B2 (en) 1993-11-04

Family

ID=6399970

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71029/91A Ceased AU642961B2 (en) 1990-02-13 1991-02-13 Pharmaceutical composition

Country Status (16)

Country Link
EP (1) EP0442141B1 (en)
JP (1) JPH04234813A (en)
KR (1) KR910015294A (en)
AT (1) ATE102031T1 (en)
AU (1) AU642961B2 (en)
CA (1) CA2036091A1 (en)
DE (2) DE4004268A1 (en)
DK (1) DK0442141T3 (en)
ES (1) ES2062287T3 (en)
HU (1) HU208483B (en)
IE (1) IE64207B1 (en)
IL (1) IL97211A (en)
NO (1) NO910566L (en)
NZ (1) NZ237092A (en)
PT (1) PT96719A (en)
ZA (1) ZA911074B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209071A1 (en) * 1992-03-20 1993-09-23 Merck Patent Gmbh PHARMACEUTICAL PREPARATION
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2769689A (en) * 1988-01-06 1989-07-06 Beecham Group Plc Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2769689A (en) * 1988-01-06 1989-07-06 Beecham Group Plc Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent

Also Published As

Publication number Publication date
CA2036091A1 (en) 1991-08-14
PT96719A (en) 1991-10-31
EP0442141B1 (en) 1994-03-02
NO910566L (en) 1991-08-14
DK0442141T3 (en) 1994-03-28
HU208483B (en) 1993-11-29
ATE102031T1 (en) 1994-03-15
DE4004268A1 (en) 1991-08-14
ES2062287T3 (en) 1994-12-16
IL97211A0 (en) 1992-08-18
IL97211A (en) 1995-07-31
IE64207B1 (en) 1995-07-12
JPH04234813A (en) 1992-08-24
AU7102991A (en) 1991-08-15
DE59004798D1 (en) 1994-04-07
IE910473A1 (en) 1991-08-14
ZA911074B (en) 1991-11-27
HUT59593A (en) 1992-06-29
EP0442141A1 (en) 1991-08-21
KR910015294A (en) 1991-09-30
HU910463D0 (en) 1991-08-28
NO910566D0 (en) 1991-02-12
NZ237092A (en) 1993-01-27

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
PH25319A (en)
AU1914092A (en) Novel derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
AU7461887A (en) Oral hygiene composition containing an antibacterial agent
CA2102697A1 (en) Pyrrolidine derivatives, preparation thereof and drugs containing same
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
AU4536389A (en) Anti-antherosclerotic diaryl compounds
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
ZA8944B (en) K+ channel activator/beta-blocker compositions
AU5339594A (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
AU578065B2 (en) Stabilized enzyme conjugate compositions
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
AU4075893A (en) Novel taxane derivatives, their preparation and compositions containing same
AU642961B2 (en) Pharmaceutical composition
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
AU1174588A (en) Anticonvulsant agents
TW218011B (en)
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
TW228524B (en)
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
AU6961191A (en) Synthesis, composition and medical application of cyclic pentaborate compounds
IL75166A (en) 2-substituted spiro(1,3-oxathiolane-5,3-quinuclidine)derivatives,their preparation and pharmaceutical compositions containing them and 3-hydroxy-3-mercaptomethylquinuclidine as intermidiate therefor